Journal of Gastrointestinal Oncology

Papers
(The H4-Index of Journal of Gastrointestinal Oncology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management84
The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma70
The inhibitory effects of probiotics on colon cancer cells: in vitro and in vivo studies37
Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression35
Exosomal miR-30a and miR-222 derived from colon cancer mesenchymal stem cells promote the tumorigenicity of colon cancer through targeting MIA331
Highly expressed Claudin18.2 as a potential therapeutic target in advanced gastric signet-ring cell carcinoma (SRCC)27
Comparison of efficacy and safety between pembrolizumab combined with chemotherapy and simple chemotherapy in neoadjuvant therapy for esophageal squamous cell carcinoma25
Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer24
Toripalimab combined with docetaxel and cisplatin neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a single-center, single-arm clinical trial (ESONICT-2)22
Hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases: lessons learned from PRODIGE 720
PD-L1 immunohistochemistry comparison of 22C3 and 28-8 assays for gastric cancer19
Prognostic value of systemic immune-inflammatory index in survival outcome in gastric cancer: a meta-analysis18
Omics analyses in peritoneal metastasis—utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review18
Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases—a systematic review17
Favorable tumor biology in locally advanced pancreatic cancer—beyond CA19-917
Esophageal cancer: the rise of adenocarcinoma over squamous cell carcinoma in the Asian belt17
Colorectal cancer surgery in elderly patients 80 years and older: a comparison with younger age groups17
0.46355795860291